We have located links that may give you full text access.
Association between lung function, physical activity level and postural evaluation variables in adult patients with cystic fibrosis.
Clinical Respiratory Journal 2018 April
INTRODUCTION: With the evolution of the cystic fibrosis (CF) disease, the decline of lung function associated with metabolic disorders and malnutrition, causes alterations in respiratory mechanics, musculoskeletal disorders and thoracic deformities, bringing injury to the individual's quality of life.
OBJECTIVE: To verify the association between lung function, physical activity level and postural evaluation variables in adults with CF.
METHODS: All patients underwent clinical evaluation and spirometry. The International Physical Activity Questionnaire (IPAQ) and an accelerometer were used to verify the physical activity level (PA). Photogrammetry was used with the aid of the Software of postural evaluation (SAPO) and, for complementary comparisons, the 6-minute walk test (6MWT) was used.
RESULTS: Twenty-eight adult subjects with CF, mean age of 25.1 ± 6.3 years and mean expiratory volume in the first second (FEV1 ) of 47.1 ± 20.9% of the predicted group participated in the study. The FEV1 correlated with the parameters obtained by the accelerometer (r = 0.723, P = .000), postural evaluation (r = -0.483, P = .005) and 6MWT (r = 0.439, P = .019), but there was no correlation with the data obtained by IPAQ (r = -0.282; P = .073). The time in which each individual remained in moderate to vigorous physical activity correlated with parameters of postural evaluation (thoracic kyphosis r = -0.484, P = .031, cervical lordosis r = 0.531, P = .016), 6MWT (r = 0.564; P = .010) and with the total METS obtained by IPAQ (r = 0.451, P = .046).
CONCLUSIONS: Lung function in patients with CF disease is associated with higher thoracic kyphosis, shorter time in moderate and vigorous PA, and shorter distance covered in 6MWT. The accelerometer has been shown to be the best instrument for assessing PA in this public.
OBJECTIVE: To verify the association between lung function, physical activity level and postural evaluation variables in adults with CF.
METHODS: All patients underwent clinical evaluation and spirometry. The International Physical Activity Questionnaire (IPAQ) and an accelerometer were used to verify the physical activity level (PA). Photogrammetry was used with the aid of the Software of postural evaluation (SAPO) and, for complementary comparisons, the 6-minute walk test (6MWT) was used.
RESULTS: Twenty-eight adult subjects with CF, mean age of 25.1 ± 6.3 years and mean expiratory volume in the first second (FEV1 ) of 47.1 ± 20.9% of the predicted group participated in the study. The FEV1 correlated with the parameters obtained by the accelerometer (r = 0.723, P = .000), postural evaluation (r = -0.483, P = .005) and 6MWT (r = 0.439, P = .019), but there was no correlation with the data obtained by IPAQ (r = -0.282; P = .073). The time in which each individual remained in moderate to vigorous physical activity correlated with parameters of postural evaluation (thoracic kyphosis r = -0.484, P = .031, cervical lordosis r = 0.531, P = .016), 6MWT (r = 0.564; P = .010) and with the total METS obtained by IPAQ (r = 0.451, P = .046).
CONCLUSIONS: Lung function in patients with CF disease is associated with higher thoracic kyphosis, shorter time in moderate and vigorous PA, and shorter distance covered in 6MWT. The accelerometer has been shown to be the best instrument for assessing PA in this public.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app